FDA advisers vote to include an Omicron-specific component for a coronavirus booster in the US

The US Food and Drug Administration's independent Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted Tuesday to support recommending inclusion of an Omicron specific component for a Covid-19 booster vaccine.

Post a Comment

Previous Post Next Post